BIO.News Newsletter

We’re live in Washington, D.C., for BIO’s Patient & Health Advocacy Summit—watch here for highlights. Meanwhile, we look at proposed changes to Medicaid drug coverage and FTC’s merger guidelines, and what they mean for biotech innovation. (567 words, 2 minutes, 50 seconds)

Closing out a busy week with a preview of today’s US — EU Summit and how biotech is boosting beer production—plus, what you missed at the BIO Investor Forum in San Francisco. (680 words, 3 minutes, 24 seconds)

The 2023 BIO Investor Forum wraps with a look at the impact of the Inflation Reduction Act on investment—and the powerful potential of AI in developing new cures. Plus, we recap a Senate HELP hearing on the nomination of Monica Bertagnolli, M.D., for NIH director. (597 words, 2 minutes, 59 seconds)

The USITC releases its recommendations for USTR’s next steps on the COVID IP waiver. Plus, our coverage of the BIO Investor Forum continues. (664 words, 3 minutes, 19 seconds)

Good Day BIO and Bio.News are on the ground at the BIO Investor Forum in San Francisco—we preview the event with a new podcast episode. Plus, BIO recognizes Indiana Governor Eric Holcomb and we’re watching for a critical report to guide USTR’s next steps on the COVID IP waiver. (650 words, 3 minutes, 15 seconds)

Friday brought positive developments: Medicare expanded coverage of a critically important PET scan before Alzheimer’s treatment, and the SEC tightened regulation of speculators who harm biotech. Plus, we have news on the launch of the Women’s Health Opportunity Map. (605 words, 3 minutes, 1 second)

Today, we learn about recent BIO delegations to Geneva and Tokyo—and share how you can support a BIO member company that discovered natural antimicrobials in the coral reef. Also, biotech companies and CEOs react to the conflict in Israel. (707 words, 3 minutes, 32 seconds)

BIO’s working to ensure small biotechs can access R&D tax deductions and support with grant funding—we have details on that, as well as the launch of TrueTrials. Don't miss BIO CEO Rachel King's op-ed in Fortune about why we need to support women in STEM. (461 words, 2 minutes, 18 seconds)

BIO CEO Rachel King joined Maryland Gov. Wes Moore at the University of Maryland BioPark yesterday, where Maryland’s innovative bioeconomy was on full display. Meanwhile, good news and bad news on bird flu highlights the need for biotech solutions to address human and animal health. (479 words, 2 minutes, 23 seconds)

New data highlights the need for the most vulnerable to get updated vaccines, while a growing body of evidence highlights the impact of climate change on our health (and what biotech can do on both fronts). (432 words, 2 minutes, 9 seconds)